Literature DB >> 2850052

Postmarketing surveillance of enalapril 1.

.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2850052      PMCID： PMC1834696          DOI： 10.1136/bmj.297.6658.1269-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Angiotensin converting enzyme inhibitors.

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

Review 2.  Review of the overall experience of captopril in hypertension.

Authors:  E D Frohlich; R A Cooper; E J Lewis
Journal:  Arch Intern Med       Date:  1984-07

3.  Post marketing surveillance of captopril (for hypertension): a preliminary report.

Authors:  D Chalmers; S L Dombey; D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

4.  Comparison of captopril and enalapril in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; M Yushak; N Medina
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

5.  Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice.

Authors:  W D Cooper; D Sheldon; D Brown; G R Kimber; V L Isitt; W J Currie
Journal:  J R Coll Gen Pract       Date:  1987-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.